» Articles » PMID: 29720192

The Impact of Severe Haemophilia and the Presence of Target Joints on Health-related Quality-of-life

Overview
Publisher Biomed Central
Specialty Public Health
Date 2018 May 4
PMID 29720192
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Joint damage remains a major complication associated with haemophilia and is widely accepted as one of the most debilitating symptoms for persons with severe haemophilia. The aim of this study is to describe how complications of haemophilia such as target joints influence health-related quality of life (HRQOL).

Methods: Data on hemophilia patients without inhibitors were drawn from the 'Cost of Haemophilia across Europe - a Socioeconomic Survey' (CHESS) study, a cost-of-illness assessment in severe haemophilia A and B across five European countries (France, Germany, Italy, Spain, and the UK). Physicians provided clinical and sociodemographic information for 1285 adult patients, 551 of whom completed corresponding questionnaires, including EQ-5D. A generalised linear model was developed to investigate the relationship between EQ-5D index score and target joint status (defined in the CHESS study as areas of chronic synovitis), adjusted for patient covariates including socio-demographic characteristics and comorbidities.

Results: Five hundred and fifteen patients (42% of the sample) provided an EQ-5D response; a total of 692 target joints were recorded across the sample. Mean EQ-5D index score for patients with no target joints was 0.875 (standard deviation [SD] 0.179); for patients with one or more target joints, mean index score was 0.731 (SD 0.285). Compared to having no target joints, having one or more target joints was associated with lower index scores (average marginal effect (AME) -0.120; SD 0.0262; p < 0.000).

Conclusions: This study found that the presence of chronic synovitis has a significant negative impact on HRQOL for adults with severe haemophilia. Prevention, early diagnosis and treatment of target joints should be an important consideration for clinicians and patients when managing haemophilia.

Citing Articles

An assessment of burden associated with problem joints in children and adults with moderate or severe haemophilia A: analysis of the CHESS-Paediatrics and CHESS II cross-sectional studies.

McLaughlin P, De la Corte-Rodriguez H, Burke T, Nissen F, Aizenas M, Moreno K Orphanet J Rare Dis. 2025; 20(1):18.

PMID: 39806420 PMC: 11726912. DOI: 10.1186/s13023-024-03514-1.


Distribution and predictors of haemophilia-related costs in the United Kingdom: analysis of the CHESS I and CHESS II burden of illness studies.

Woollacott I, Chhabra A, Burke T, Brownrigg J, Richardson L, Ferri Grazzi E BMC Health Serv Res. 2024; 24(1):1437.

PMID: 39563410 PMC: 11577900. DOI: 10.1186/s12913-024-11850-y.


Performance of instrumental activities of daily living in patients with haemophilic arthropathy. A cross-sectional cohort study.

Seoane-Martin M, Cuesta-Barriuso R, Rodriguez-Martinez M Haemophilia. 2024; 30(6):1406-1413.

PMID: 39447049 PMC: 11659492. DOI: 10.1111/hae.15114.


Superior Prophylactic Effectiveness of a Recombinant FVIIIFc Over Standard Half-Life FVIII in Hemophilia A: A-SURE Study.

Oldenburg J, Hay C, Peyvandi F, Tagliaferri A, Holme P, Alvarez-Roman M Eur J Haematol. 2024; 114(2):248-257.

PMID: 39434416 PMC: 11707817. DOI: 10.1111/ejh.14309.


Assessment of joint health in patients receiving prophylaxis for haemophilia A: a cross-sectional survey in five European countries.

De la Corte-Rodriguez H, Bystricka L, Ball N, Olsen S, Golden K, Hakimi Z BMJ Open. 2024; 14(9):e082204.

PMID: 39260833 PMC: 11409238. DOI: 10.1136/bmjopen-2023-082204.


References
1.
Rossbach H . Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia A. Vasc Health Risk Manag. 2010; 6:59-68. PMC: 2835555. DOI: 10.2147/vhrm.s5217. View

2.
Monahan P, Baker J, Riske B, Soucie J . Physical functioning in boys with hemophilia in the U.S. Am J Prev Med. 2011; 41(6 Suppl 4):S360-8. DOI: 10.1016/j.amepre.2011.09.017. View

3.
Goddard N, Mann H . Diagnosis of haemophilic synovitis. Haemophilia. 2007; 13 Suppl 3:14-9. DOI: 10.1111/j.1365-2516.2007.01535.x. View

4.
Blanchette V, Key N, Ljung L, Manco-Johnson M, van den Berg H, Srivastava A . Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014; 12(11):1935-9. DOI: 10.1111/jth.12672. View

5.
Manning W, Mullahy J . Estimating log models: to transform or not to transform?. J Health Econ. 2001; 20(4):461-94. DOI: 10.1016/s0167-6296(01)00086-8. View